France, Germany and Italy suspend use of AstraZeneca vaccine

Monday, March 15

France and Germany said they will stop administering AstraZeneca's Covid-19 vaccine as a "precaution" pending a new assessment by the European Union's medicines regulator.

French President Emmanuel Macron told a press conference today that a “decision has been made ... to suspend the use of the AstraZeneca vaccine as a precaution, hoping that we can resume its use quickly if the judgement of the EMA (European Medicines Agency) allows it." 

The German government earlier said that it was suspending the use of AstraZeneca’s vaccine over reports of dangerous blood clots in connection with the shot. 

Germany's health ministry said the decision was taken as a precaution and on the advice of their national vaccine regulator, the PEI.

“After new reports of thromboses of the cerebral veins in connection with the vaccination in Germany and Europe, the PEI considers further investigations to be necessary,” said the health ministry.

“The European Medicines Agency will decide whether and how the new findings will affect the approval of the vaccine,” it added.

Italy's medicines regulator, AIFA, also said the suspension was a "precautionary and temporary measure" pending the EMA's recommendation.

Several European countries including Denmark, Norway, Ireland and the Netherlands have already suspend

The World Health Organization (WHO) has said there was no link between the jab and an increased risk of developing a clot, adding countries should not stop the use of AstraZeneca's vaccine.ed usage of the shots.

Both AstraZeneca and Oxford have said there is no link between their vaccine and blood clotting.

The company had said the 15 incidences of deep vein thrombosis (DVT) and 22 events of pulmonary embolism reported among those given the vaccine was “much lower than would be expected to occur naturally in a general population”.

Newsday and Agencies